Evidence map›Paper›PMID 35241084›Full record

ArticleHealth and quality of life outcomes2022

Quality of life and informal care burden associated with duchenne muscular dystrophy in Portugal: the COIDUCH study.

Valeska Andreozzi, Pedro Labisa, Melina Mota, Susana Monteiro, Rita Alves, João Almeida, Björn Vandewalle, Jorge Felix, Katharina Buesch, Hugo Canhão and 1 more

Abstract read
In one paragraph

Article in Health and quality of life outcomes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Valeska AndreozziExigo Consultores, Lisbon, Portugal.
Pedro LabisaExigo Consultores, Lisbon, Portugal.
Melina MotaExigo Consultores, Lisbon, Portugal. melina.mota@exigoconsultores.com.ORCID http://orcid.org/0000-0002-6194-7690
Susana MonteiroExigo Consultores, Lisbon, Portugal.
Rita AlvesExigo Consultores, Lisbon, Portugal.
João AlmeidaExigo Consultores, Lisbon, Portugal.
Björn VandewalleExigo Consultores, Lisbon, Portugal.
Jorge FelixExigo Consultores, Lisbon, Portugal.
Katharina BueschPTC Therapeutics International, Steinhausen, Switzerland.
Hugo CanhãoPTC Therapeutics Portugal, Sintra, Portugal.
Igor Beitia Ortiz de ZaratePTC Therapeutics Portugal, Sintra, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo describe the reduced health-related quality of life (HRQoL) of duchenne muscular dystrophy (DMD) patients and their caregiver burden and to present its relationship with disease progression.

methodsThis cross-sectional study assessed patient HRQoL with the 3-level version of the EuroQol-5D (EQ-5D-3L) and caregiver burden with the Work Productivity and Activity Impairment: General Health questionnaire. DMD patients and their caregivers were identified through Portuguese Neuromuscular Association (APN).

resultsA total of 46 DMD main caregivers, of eight ambulant and 38 non-ambulant patients, completed the questionnaires. Over half (58.7%) of all non-ambulant patients were on ventilation support, either full-time (15.2%) or non full-time (43.5%). Non-ambulant patients had a lower mean utility scores than ambulant patients (- 0.05 versus 0.51, p value < 0.001). Caregivers of non-ambulant patients reported a significant mean daily activity impairment as compared to caregivers of ambulant patients (68% versus 23%, p value < 0.001). Among non-ambulant patients, both utility scores and caregiver impairment appeared to deteriorate according to a higher need for ventilation support, however, these results were not statistically significant.

conclusionsThese results emphasise the significant negative impact that DMD progression has on the patient HRQoL, as well as caregivers' ability to conduct their daily activities. Therapeutic options that stop or slow the disease progression could have a beneficial impact for both patients and caregivers.

Indexed as

Muscular Dystrophy, DuchenneQuality of LifeCaregiver BurdenCaregiversCross-Sectional StudiesHumansPatient CarePortugalSurveys and QuestionnairesDisease progressionDuchenne muscular dystrophyInformal care burdenQuality of life

Identifiers

PMID35241084
PMCPMC8896234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.